MENU
FATE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fate Therapeutics (FATE) Ownership - Who owns Fate Therapeutics?
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
119.22M
P/E Ratio
N/A
Total Cash
240.43M
Projected Growth
N/A
Total Debt
83.33M
Revenue
13.34M
Risk (Beta)
2.24
Dividend Yield
N/A
Total Cash/Share
2.10
Total Debt/Equity
2.75
Revenue/Share
0.11 USD as % of share price
Fundamentals
FATE
Capitalization
119M
P/E Ratio
N/A
Risk (Beta)
2.24
Dividend Yield
N/A
Total Cash
240M
Total Cash/Share
2.10
Total Debt
83.3M
Total Debt/Equity
2.75
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.11%
Revenue
13.3M
ROE
N/A
Book Value
288M
P/B Ratio
0.41
Cash Flow
N/A
Earnings
-1.49
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
115K
Current Ratio
8.81
Current Revenue Per Employee
9000.00
Dividends Per Share - Security
N/A
EBITDA
-168.28M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-36.32
Shares Held By Institutions
135M
Shares Outstanding - Current
115M
Total Liabilities
110M
Total Volume MTD
N/A
Value
1
Gain YTD
-36.970
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com